Introduction
Adrian Padfield FRCA J R Soc Mecl1996; 89:277P Over the last 50 years anaesthesia has advanced from an art learnt 'hands-on' and mostly practised part-time by general practitioners to one of the most scientific specialties in hospital medicine. The burgeoning of the speciality has allowed the magnitude and complexity of surgery to increase to an extent that could not have been envisaged SO years ago. It attracts doctors who, whether they exercise a wide range of highly specialized practical skills or indulge in esoteric basic research, see the patients in terms of their overall medical conditions. Anaesthetic practice has a much more perioperative role than a generation ago so modern anaesthetic training must encompass a wide knowledge of medical diseases and of the drugs and medications used in other specialties as well as a complete understanding of the agents used in anaesthesia (including their rarest side-effects). However, one of the great strengths of British anaesthesia is the wide practical experience that has been maintained-undiluted by nonmedical anaesthetists.
The introduction of muscle relaxants, intermittent positive pressure ventilation, and new local and general anaesthetic agents together with new techniques, equipment and sophisticated monitoring allow anaesthetists to manage patients who, even 30 years ago, would have been considered far too risky to be subjected to the rigours of (less complex) surgery. The success of modern anaesthesia occasionally leads to rather blase surgical attitudes and narrow perspectives when the overall well-being of patients and their future quality of life should be considered.
Highly elaborate surgery can now be carried out on patients with serious and life threatening illnesses. Also, technically straightforward surgery may be performed on patients whose medical conditions and treatment can bedevil their anaesthetic management. The three papers by Alderson, Conacher, and Reilly, presented at a meeting of the Section of Anaesthesia, illustrate some problems posed by patients with unusual and complex conditions needing surgery and show how these can be overcome with modem perioperative anaesthetic management. (Accepted 30 AUBust 1995) function, leading to loss of sensation and muscle tone, loss of movement and autonomic failure in the area that the spinal cord supplies. This 'spinal shock' can be compared with the effects of a spinal anaesthetic of the same dermatome height, and it is therefore possible to predict the objective signs. If the injury is cervical then respiration will be considerably compromised. Also a total sympathectomy will have been performed, leading to low blood pressure, low pulse rate and low cardiac output. It must be remembered that in this situation the cranial parasympathetic nerves will still be functioning normally; therefore stimulation of the vagus nerve, in particular, may worsen the cardiovascular state by causing bradycardia and even cardiac standstill. This is particularly likely to happen during endotracheal intubation, tracheal aspiration, and pharyngeal aspiration, and should be 277P JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
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prevented by prior treatment with antimuscarinic agents such as atropine. Intubation of an unstable neck injury demands expertise in intubation, with the spine held in a neutral position. Cricoid pressure is best avoided, but suxamethonium can be used during the first day or so after injury. After a few more days the denervated neuromuscular junctions become exquisitely sensitive to suxamethonium, leading to a large rise in serum potassium concentrations, which can produce cardiac standstill. This agent should therefore be avoided after the first few days, probably for the next year.
After a period of a week or so the spinal cord below the injury enters the reflex phase, manifested by increase in muscle tone in the denervated muscles and the development of spinal reflexes of both muscular and autonomic type. The autonomic reflexes (autonomic hyperreflexia) are of particular concern to the anaesthetist, as these are often Moo 1996; 89:278P A programme of laser therapy for subglottic tracheobronchial disease was started in 1983 1 • By 1995 more than 300 patients had been treated and some 550 treatment sessions administered. All were undertaken with general anaesthesia. During 1991-1994 approximately 30-40 new patients were seen each year and between 48 and 79 treatment sessions undertaken. Early experience was with a carbon dioxide laser (C0 2 ) , but we now use a neodymium yttrium aluminium garnet laser (Nd:YAG).
Anaesthesia for endobronchial laser surgery
The general anaesthetic technique had been established by 1988 and is based on: a rigid bronchoscope to establish and maintain an airway; total intravenous anaesthesia (TIVA) with propofol; and profound, but rapidly reversible, muscle relaxation with suxamethonium by infusion. Jet ventilation is delivered from a custombuilt ventilator/. The anaesthetic process has proved safe but vigilance is necessary because of fire risk: ventilation, albeit delivered through metal instrumentation and with avoidance of inflammable materials, depends on a high Department of Anaesthesia, Freeman Trust Hospitals, Newcastle upon Tyne NE7 7DN, England initiated by surgical stimulation, in particular bladder distension. Injuries above T6 are associated with special hazards including blood pressure rises to dangerous levels, associated with bradycardia. The anaesthetist must identify those patients at risk of this syndrome, and formulate a plan of action to control this reflex or the resulting blood pressure rise. My own preference is for spinal anaesthesia, which converts the hyperreflexic spinal cord below the injury to the previous spinal shock pattern. Other methods include the use of potent intravenous hypotensive agents, or general anaesthesia with a volatile agent to damp down the response. Without such a plan the patient is at risk of death from cerebral haemorrhage. (Accepted 30 AUBust /995) inspired concentration of oxygen. The potential for fire in the airway has been increased by the stream of air that is part of the laser cooling system at the tip of the laser fibre directly in the line of lesions being treated.
The bulk of this vulnerable patient population benefit substantially. There is a small risk in treating and anaesthetizing them. The 8-year experience of the use of the CO 2 laser for malignant tracheo-bronchial tumours has been reviewed". Of 142 patients, three died within 24h of treatment. There was an 18% 30-day mortality. Relief of dyspnoea was claimed by 103 of the 116 in whom breathlessness was the main symptom. Pulmonary function tests showed significant improvements. The mean post-laser survival was 5 months. Two-year survival was achieved in some patients who would otherwise have been expected to be dead within 6 months after diagnosis of their inoperable bronchogenic tumour.
